{"altmetric_id":4687412,"citation":{"altmetric_jid":"clinicaltrialsgov","authors":["Boston Scientific Corporation"],"first_seen_on":"2015-10-28T12:25:51+00:00","issns":[],"journal":"ClinicalTrials.gov","last_mentioned_on":1389290359,"links":["http:\/\/www.clinicaltrials.gov\/ct2\/show\/NCT01541865?term=REDUCE+HTN&rank=1"],"nct_id":"NCT01541865","pubdate":"2012-02-21T00:00:00+00:00","publisher":"ClinicalTrials.gov","title":"Treatment of Resistant Hypertension Using a Radiofrequency Percutaneous Transluminal Angioplasty Catheter (REDUCE-HTN)","type":"clinical_trial_study_record"},"altmetric_score":{"score":7,"score_history":{"1y":0,"6m":0,"3m":0,"1m":0,"1w":0,"6d":0,"5d":0,"4d":0,"3d":0,"2d":0,"1d":0,"at":7},"context_for_score":{"all":{"total_number_of_other_articles":4426439,"mean":4.8112999858163,"rank":534873,"this_scored_higher_than_pct":87,"this_scored_higher_than":3868485,"rank_type":"exact","sample_size":4426439,"percentile":87},"similar_age_3m":{"total_number_of_other_articles":76049,"mean":5.3779067694088,"rank":8986,"this_scored_higher_than_pct":87,"this_scored_higher_than":66869,"rank_type":"exact","sample_size":76049,"percentile":87},"this_journal":{"total_number_of_other_articles":3070,"mean":2.7178429455849,"rank":294,"this_scored_higher_than_pct":93,"this_scored_higher_than":2869,"rank_type":"exact","sample_size":3070,"percentile":93},"similar_age_this_journal_3m":{"total_number_of_other_articles":209,"mean":1.6024038461538,"rank":5,"this_scored_higher_than_pct":96,"this_scored_higher_than":202,"rank_type":"exact","sample_size":209,"percentile":96}}},"demographics":[],"counts":{"total":{"posts_count":1},"news":{"unique_users_count":1,"unique_users":["medscape"],"posts_count":1}},"posts":{"news":[{"title":"Renal Denervation Fails in SYMPLICITY HTN-3","url":"http:\/\/www.medscape.com\/viewarticle\/818938","license":"public","citation_ids":[4687412,4687413,4687414,4687415],"posted_on":"2014-01-09T17:59:19+00:00","summary":"In a blow to the excitement surrounding renal denervation for the treatment of resistant hypertension, the trial, which included a sham-control arm, found no effect on systolic blood pressure. News Alerts","author":{"name":"Medscape","url":"http:\/\/medscape.com\/","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/000\/055\/normal\/medscape.png?1369846939"}}]}}